🔎 Trials Near Me

Home › Down Syndrome › Pennsylvania

Pag-aaral pangklinika para sa Down Syndrome sa Pennsylvania

6 pag-aaral para sa Down Syndrome ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

Down Syndrome Obstructive Sleep Apnea

  • Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 2
Edad 5 hanggang 18 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06043440

Endotype DIrected Treatment for OSA in Down Syndrome

  • Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 4
Edad 6 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07280468

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • at 3 pa
Nagre-recruitPhase 2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Edad 6 hanggang 39 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05702645

Collaboration for Down Syndrome Progress (CDP)

  • The Children's Hospital of Philadelphia, Philadelphia
  • The Children's Hospital of Philadelphia, Philadelphia
  • University of Pittsburgh, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT07625579

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Edad 25 hanggang 55 · Lahat ng kasarian · Na-update May 18, 2026 · NCT04165109

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.